What are you looking for?

Need help finding what you are looking for? Contact Us

Compare

Free Samples

Home Market Research Reports Medical Device

PUBLISHER: QYResearch | PRODUCT CODE: 1873498

PUBLISHER: QYResearch | PRODUCT CODE: 1873498

Hemoperfusion - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

PUBLISHED: October 24, 2025

PAGES: 90 Pages

DELIVERY TIME: 2-3 business days

ADD TO COMPARE

SELECT AN OPTION

The global market for Hemoperfusion was estimated to be worth US$ 697 million in 2024 and is forecast to a readjusted size of US$ 2199 million by 2031 with a CAGR of 18.1% during the forecast period 2025-2031.

This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Hemoperfusion cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.

Hemoperfusion is a treatment technique in which large volumes of the patient's blood are passed over an adsorbent substance in order to remove toxic substances from the blood. Adsorption is a process in which molecules or particles of one substance are attracted to the surface of a solid material and held there. These solid materials are called sorbents.

The hemoperfusion market is experiencing growing interest as healthcare providers increasingly adopt advanced blood purification techniques to manage various critical conditions, including drug overdoses, sepsis, and autoimmune diseases. Hemoperfusion, which involves passing blood through an adsorbent-containing cartridge to remove toxins, offers targeted and efficient detoxification that traditional dialysis cannot always achieve. This capability makes it particularly valuable in emergency care and intensive care settings, driving its adoption in hospitals and specialized clinics worldwide.

Additionally, technological advancements in cartridge materials and the integration of hemoperfusion with other extracorporeal therapies are enhancing the efficacy and safety of treatments. As awareness of its clinical benefits spreads and regulatory support strengthens, more healthcare systems in both developed and emerging markets are incorporating hemoperfusion into standard care protocols. However, market growth may still face challenges such as limited practitioner familiarity and cost considerations, which need to be addressed through education and innovation.

This report aims to provide a comprehensive presentation of the global market for Hemoperfusion, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Hemoperfusion by region & country, by Type, and by Application.

The Hemoperfusion market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hemoperfusion.

Market Segmentation

By Company

Jianfan Biotech
Kangbei Medical
Foshan Boxin (Lily Medical)
Baxter
Asahi Kasei

Segment by Type

Activated Carbon Adsorption
Resin Adsorption

Segment by Application

Hepatic Encephalopathy
Certain Autoimmune Diseases
Drug Overdose
Specific Intoxications
Others

By Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Hemoperfusion manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Sales, revenue of Hemoperfusion in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Sales, revenue of Hemoperfusion in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

1 Market Overview

1.1 Hemoperfusion Product Introduction
1.2 Global Hemoperfusion Market Size Forecast
- 1.2.1 Global Hemoperfusion Sales Value (2020-2031)
- 1.2.2 Global Hemoperfusion Sales Volume (2020-2031)
- 1.2.3 Global Hemoperfusion Sales Price (2020-2031)
1.3 Hemoperfusion Market Trends & Drivers
- 1.3.1 Hemoperfusion Industry Trends
- 1.3.2 Hemoperfusion Market Drivers & Opportunity
- 1.3.3 Hemoperfusion Market Challenges
- 1.3.4 Hemoperfusion Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Hemoperfusion Players Revenue Ranking (2024)
2.2 Global Hemoperfusion Revenue by Company (2020-2025)
2.3 Global Hemoperfusion Players Sales Volume Ranking (2024)
2.4 Global Hemoperfusion Sales Volume by Company Players (2020-2025)
2.5 Global Hemoperfusion Average Price by Company (2020-2025)
2.6 Key Manufacturers Hemoperfusion Manufacturing Base and Headquarters
2.7 Key Manufacturers Hemoperfusion Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Hemoperfusion
2.9 Hemoperfusion Market Competitive Analysis
- 2.9.1 Hemoperfusion Market Concentration Rate (2020-2025)
- 2.9.2 Global 5 and 10 Largest Manufacturers by Hemoperfusion Revenue in 2024
- 2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hemoperfusion as of 2024)
2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type
- 3.1.1 Activated Carbon Adsorption
- 3.1.2 Resin Adsorption
3.2 Global Hemoperfusion Sales Value by Type
- 3.2.1 Global Hemoperfusion Sales Value by Type (2020 VS 2024 VS 2031)
- 3.2.2 Global Hemoperfusion Sales Value, by Type (2020-2031)
- 3.2.3 Global Hemoperfusion Sales Value, by Type (%) (2020-2031)
3.3 Global Hemoperfusion Sales Volume by Type
- 3.3.1 Global Hemoperfusion Sales Volume by Type (2020 VS 2024 VS 2031)
- 3.3.2 Global Hemoperfusion Sales Volume, by Type (2020-2031)
- 3.3.3 Global Hemoperfusion Sales Volume, by Type (%) (2020-2031)
3.4 Global Hemoperfusion Average Price by Type (2020-2031)

4 Segmentation by Application

4.1 Introduction by Application
- 4.1.1 Hepatic Encephalopathy
- 4.1.2 Certain Autoimmune Diseases
- 4.1.3 Drug Overdose
- 4.1.4 Specific Intoxications
- 4.1.5 Others
4.2 Global Hemoperfusion Sales Value by Application
- 4.2.1 Global Hemoperfusion Sales Value by Application (2020 VS 2024 VS 2031)
- 4.2.2 Global Hemoperfusion Sales Value, by Application (2020-2031)
- 4.2.3 Global Hemoperfusion Sales Value, by Application (%) (2020-2031)
4.3 Global Hemoperfusion Sales Volume by Application
- 4.3.1 Global Hemoperfusion Sales Volume by Application (2020 VS 2024 VS 2031)
- 4.3.2 Global Hemoperfusion Sales Volume, by Application (2020-2031)
- 4.3.3 Global Hemoperfusion Sales Volume, by Application (%) (2020-2031)
4.4 Global Hemoperfusion Average Price by Application (2020-2031)

5 Segmentation by Region

5.1 Global Hemoperfusion Sales Value by Region
- 5.1.1 Global Hemoperfusion Sales Value by Region: 2020 VS 2024 VS 2031
- 5.1.2 Global Hemoperfusion Sales Value by Region (2020-2025)
- 5.1.3 Global Hemoperfusion Sales Value by Region (2026-2031)
- 5.1.4 Global Hemoperfusion Sales Value by Region (%), (2020-2031)
5.2 Global Hemoperfusion Sales Volume by Region
- 5.2.1 Global Hemoperfusion Sales Volume by Region: 2020 VS 2024 VS 2031
- 5.2.2 Global Hemoperfusion Sales Volume by Region (2020-2025)
- 5.2.3 Global Hemoperfusion Sales Volume by Region (2026-2031)
- 5.2.4 Global Hemoperfusion Sales Volume by Region (%), (2020-2031)
5.3 Global Hemoperfusion Average Price by Region (2020-2031)
5.4 North America
- 5.4.1 North America Hemoperfusion Sales Value, 2020-2031
- 5.4.2 North America Hemoperfusion Sales Value by Country (%), 2024 VS 2031
5.5 Europe
- 5.5.1 Europe Hemoperfusion Sales Value, 2020-2031
- 5.5.2 Europe Hemoperfusion Sales Value by Country (%), 2024 VS 2031
5.6 Asia Pacific
- 5.6.1 Asia Pacific Hemoperfusion Sales Value, 2020-2031
- 5.6.2 Asia Pacific Hemoperfusion Sales Value by Region (%), 2024 VS 2031
5.7 South America
- 5.7.1 South America Hemoperfusion Sales Value, 2020-2031
- 5.7.2 South America Hemoperfusion Sales Value by Country (%), 2024 VS 2031
5.8 Middle East & Africa
- 5.8.1 Middle East & Africa Hemoperfusion Sales Value, 2020-2031
- 5.8.2 Middle East & Africa Hemoperfusion Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Hemoperfusion Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions Hemoperfusion Sales Value and Sales Volume
- 6.2.1 Key Countries/Regions Hemoperfusion Sales Value, 2020-2031
- 6.2.2 Key Countries/Regions Hemoperfusion Sales Volume, 2020-2031
6.3 United States
- 6.3.1 United States Hemoperfusion Sales Value, 2020-2031
- 6.3.2 United States Hemoperfusion Sales Value by Type (%), 2024 VS 2031
- 6.3.3 United States Hemoperfusion Sales Value by Application, 2024 VS 2031
6.4 Europe
- 6.4.1 Europe Hemoperfusion Sales Value, 2020-2031
- 6.4.2 Europe Hemoperfusion Sales Value by Type (%), 2024 VS 2031
- 6.4.3 Europe Hemoperfusion Sales Value by Application, 2024 VS 2031
6.5 China
- 6.5.1 China Hemoperfusion Sales Value, 2020-2031
- 6.5.2 China Hemoperfusion Sales Value by Type (%), 2024 VS 2031
- 6.5.3 China Hemoperfusion Sales Value by Application, 2024 VS 2031
6.6 Japan
- 6.6.1 Japan Hemoperfusion Sales Value, 2020-2031
- 6.6.2 Japan Hemoperfusion Sales Value by Type (%), 2024 VS 2031
- 6.6.3 Japan Hemoperfusion Sales Value by Application, 2024 VS 2031
6.7 South Korea
- 6.7.1 South Korea Hemoperfusion Sales Value, 2020-2031
- 6.7.2 South Korea Hemoperfusion Sales Value by Type (%), 2024 VS 2031
- 6.7.3 South Korea Hemoperfusion Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
- 6.8.1 Southeast Asia Hemoperfusion Sales Value, 2020-2031
- 6.8.2 Southeast Asia Hemoperfusion Sales Value by Type (%), 2024 VS 2031
- 6.8.3 Southeast Asia Hemoperfusion Sales Value by Application, 2024 VS 2031
6.9 India
- 6.9.1 India Hemoperfusion Sales Value, 2020-2031
- 6.9.2 India Hemoperfusion Sales Value by Type (%), 2024 VS 2031
- 6.9.3 India Hemoperfusion Sales Value by Application, 2024 VS 2031

7 Company Profiles

7.1 Jianfan Biotech
- 7.1.1 Jianfan Biotech Company Information
- 7.1.2 Jianfan Biotech Introduction and Business Overview
- 7.1.3 Jianfan Biotech Hemoperfusion Sales, Revenue, Price and Gross Margin (2020-2025)
- 7.1.4 Jianfan Biotech Hemoperfusion Product Offerings
- 7.1.5 Jianfan Biotech Recent Development
7.2 Kangbei Medical
- 7.2.1 Kangbei Medical Company Information
- 7.2.2 Kangbei Medical Introduction and Business Overview
- 7.2.3 Kangbei Medical Hemoperfusion Sales, Revenue, Price and Gross Margin (2020-2025)
- 7.2.4 Kangbei Medical Hemoperfusion Product Offerings
- 7.2.5 Kangbei Medical Recent Development
7.3 Foshan Boxin (Lily Medical)
- 7.3.1 Foshan Boxin (Lily Medical) Company Information
- 7.3.2 Foshan Boxin (Lily Medical) Introduction and Business Overview
- 7.3.3 Foshan Boxin (Lily Medical) Hemoperfusion Sales, Revenue, Price and Gross Margin (2020-2025)
- 7.3.4 Foshan Boxin (Lily Medical) Hemoperfusion Product Offerings
- 7.3.5 Foshan Boxin (Lily Medical) Recent Development
7.4 Baxter
- 7.4.1 Baxter Company Information
- 7.4.2 Baxter Introduction and Business Overview
- 7.4.3 Baxter Hemoperfusion Sales, Revenue, Price and Gross Margin (2020-2025)
- 7.4.4 Baxter Hemoperfusion Product Offerings
- 7.4.5 Baxter Recent Development
7.5 Asahi Kasei
- 7.5.1 Asahi Kasei Company Information
- 7.5.2 Asahi Kasei Introduction and Business Overview
- 7.5.3 Asahi Kasei Hemoperfusion Sales, Revenue, Price and Gross Margin (2020-2025)
- 7.5.4 Asahi Kasei Hemoperfusion Product Offerings
- 7.5.5 Asahi Kasei Recent Development

8 Industry Chain Analysis

8.1 Hemoperfusion Industrial Chain
8.2 Hemoperfusion Upstream Analysis
- 8.2.1 Key Raw Materials
- 8.2.2 Raw Materials Key Suppliers
- 8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
- 8.5.1 Hemoperfusion Sales Model
- 8.5.2 Sales Channel
- 8.5.3 Hemoperfusion Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology
- 10.1.1 Methodology/Research Approach
  - 10.1.1.1 Research Programs/Design
  - 10.1.1.2 Market Size Estimation
  - 10.1.1.3 Market Breakdown and Data Triangulation
- 10.1.2 Data Source
  - 10.1.2.1 Secondary Sources
  - 10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer

List of Tables

Table 1. Hemoperfusion Market Trends
Table 2. Hemoperfusion Market Drivers & Opportunity
Table 3. Hemoperfusion Market Challenges
Table 4. Hemoperfusion Market Restraints
Table 5. Global Hemoperfusion Revenue by Company (2020-2025) & (US$ Million)
Table 6. Global Hemoperfusion Revenue Market Share by Company (2020-2025)
Table 7. Global Hemoperfusion Sales Volume by Company (2020-2025) & (K Units)
Table 8. Global Hemoperfusion Sales Volume Market Share by Company (2020-2025)
Table 9. Global Market Hemoperfusion Price by Company (2020-2025) & (USD/Unit)
Table 10. Key Manufacturers Hemoperfusion Manufacturing Base and Headquarters
Table 11. Key Manufacturers Hemoperfusion Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of Hemoperfusion
Table 13. Global Hemoperfusion Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hemoperfusion as of 2024)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Hemoperfusion Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
Table 17. Global Hemoperfusion Sales Value by Type (2020-2025) & (US$ Million)
Table 18. Global Hemoperfusion Sales Value by Type (2026-2031) & (US$ Million)
Table 19. Global Hemoperfusion Sales Market Share in Value by Type (2020-2025)
Table 20. Global Hemoperfusion Sales Market Share in Value by Type (2026-2031)
Table 21. Global Hemoperfusion Sales Volume by Type: 2020 VS 2024 VS 2031 (K Units)
Table 22. Global Hemoperfusion Sales Volume by Type (2020-2025) & (K Units)
Table 23. Global Hemoperfusion Sales Volume by Type (2026-2031) & (K Units)
Table 24. Global Hemoperfusion Sales Market Share in Volume by Type (2020-2025)
Table 25. Global Hemoperfusion Sales Market Share in Volume by Type (2026-2031)
Table 26. Global Hemoperfusion Price by Type (2020-2025) & (USD/Unit)
Table 27. Global Hemoperfusion Price by Type (2026-2031) & (USD/Unit)
Table 28. Global Hemoperfusion Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
Table 29. Global Hemoperfusion Sales Value by Application (2020-2025) & (US$ Million)
Table 30. Global Hemoperfusion Sales Value by Application (2026-2031) & (US$ Million)
Table 31. Global Hemoperfusion Sales Market Share in Value by Application (2020-2025)
Table 32. Global Hemoperfusion Sales Market Share in Value by Application (2026-2031)
Table 33. Global Hemoperfusion Sales Volume by Application: 2020 VS 2024 VS 2031 (K Units)
Table 34. Global Hemoperfusion Sales Volume by Application (2020-2025) & (K Units)
Table 35. Global Hemoperfusion Sales Volume by Application (2026-2031) & (K Units)
Table 36. Global Hemoperfusion Sales Market Share in Volume by Application (2020-2025)
Table 37. Global Hemoperfusion Sales Market Share in Volume by Application (2026-2031)
Table 38. Global Hemoperfusion Price by Application (2020-2025) & (USD/Unit)
Table 39. Global Hemoperfusion Price by Application (2026-2031) & (USD/Unit)
Table 40. Global Hemoperfusion Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
Table 41. Global Hemoperfusion Sales Value by Region (2020-2025) & (US$ Million)
Table 42. Global Hemoperfusion Sales Value by Region (2026-2031) & (US$ Million)
Table 43. Global Hemoperfusion Sales Value by Region (2020-2025) & (%)
Table 44. Global Hemoperfusion Sales Value by Region (2026-2031) & (%)
Table 45. Global Hemoperfusion Sales Volume by Region (K Units): 2020 VS 2024 VS 2031
Table 46. Global Hemoperfusion Sales Volume by Region (2020-2025) & (K Units)
Table 47. Global Hemoperfusion Sales Volume by Region (2026-2031) & (K Units)
Table 48. Global Hemoperfusion Sales Volume by Region (2020-2025) & (%)
Table 49. Global Hemoperfusion Sales Volume by Region (2026-2031) & (%)
Table 50. Global Hemoperfusion Average Price by Region (2020-2025) & (USD/Unit)
Table 51. Global Hemoperfusion Average Price by Region (2026-2031) & (USD/Unit)
Table 52. Key Countries/Regions Hemoperfusion Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
Table 53. Key Countries/Regions Hemoperfusion Sales Value, (2020-2025) & (US$ Million)
Table 54. Key Countries/Regions Hemoperfusion Sales Value, (2026-2031) & (US$ Million)
Table 55. Key Countries/Regions Hemoperfusion Sales Volume, (2020-2025) & (K Units)
Table 56. Key Countries/Regions Hemoperfusion Sales Volume, (2026-2031) & (K Units)
Table 57. Jianfan Biotech Company Information
Table 58. Jianfan Biotech Introduction and Business Overview
Table 59. Jianfan Biotech Hemoperfusion Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. Jianfan Biotech Hemoperfusion Product Offerings
Table 61. Jianfan Biotech Recent Development
Table 62. Kangbei Medical Company Information
Table 63. Kangbei Medical Introduction and Business Overview
Table 64. Kangbei Medical Hemoperfusion Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 65. Kangbei Medical Hemoperfusion Product Offerings
Table 66. Kangbei Medical Recent Development
Table 67. Foshan Boxin (Lily Medical) Company Information
Table 68. Foshan Boxin (Lily Medical) Introduction and Business Overview
Table 69. Foshan Boxin (Lily Medical) Hemoperfusion Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 70. Foshan Boxin (Lily Medical) Hemoperfusion Product Offerings
Table 71. Foshan Boxin (Lily Medical) Recent Development
Table 72. Baxter Company Information
Table 73. Baxter Introduction and Business Overview
Table 74. Baxter Hemoperfusion Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 75. Baxter Hemoperfusion Product Offerings
Table 76. Baxter Recent Development
Table 77. Asahi Kasei Company Information
Table 78. Asahi Kasei Introduction and Business Overview
Table 79. Asahi Kasei Hemoperfusion Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 80. Asahi Kasei Hemoperfusion Product Offerings
Table 81. Asahi Kasei Recent Development
Table 82. Key Raw Materials Lists
Table 83. Raw Materials Key Suppliers Lists
Table 84. Hemoperfusion Downstream Customers
Table 85. Hemoperfusion Distributors List
Table 86. Research Programs/Design for This Report
Table 87. Key Data Information from Secondary Sources
Table 88. Key Data Information from Primary Sources

List of Figures

Figure 1. Hemoperfusion Product Picture
Figure 2. Global Hemoperfusion Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Global Hemoperfusion Sales Value (2020-2031) & (US$ Million)
Figure 4. Global Hemoperfusion Sales Volume (2020-2031) & (K Units)
Figure 5. Global Hemoperfusion Sales Price (2020-2031) & (USD/Unit)
Figure 6. Hemoperfusion Report Years Considered
Figure 7. Global Hemoperfusion Players Revenue Ranking (2024) & (US$ Million)
Figure 8. Global Hemoperfusion Players Sales Volume Ranking (2024) & (K Units)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Hemoperfusion Revenue in 2024
Figure 10. Hemoperfusion Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 11. Activated Carbon Adsorption Picture
Figure 12. Resin Adsorption Picture
Figure 13. Global Hemoperfusion Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
Figure 14. Global Hemoperfusion Sales Value Market Share by Type, 2024 & 2031
Figure 15. Global Hemoperfusion Sales Volume by Type (2020 VS 2024 VS 2031) & (K Units)
Figure 16. Global Hemoperfusion Sales Volume Market Share by Type, 2024 & 2031
Figure 17. Global Hemoperfusion Price by Type (2020-2031) & (USD/Unit)
Figure 18. Product Picture of Hepatic Encephalopathy
Figure 19. Product Picture of Certain Autoimmune Diseases
Figure 20. Product Picture of Drug Overdose
Figure 21. Product Picture of Specific Intoxications
Figure 22. Product Picture of Others
Figure 23. Global Hemoperfusion Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
Figure 24. Global Hemoperfusion Sales Value Market Share by Application, 2024 & 2031
Figure 25. Global Hemoperfusion Sales Volume by Application (2020 VS 2024 VS 2031) & (K Units)
Figure 26. Global Hemoperfusion Sales Volume Market Share by Application, 2024 & 2031
Figure 27. Global Hemoperfusion Price by Application (2020-2031) & (USD/Unit)
Figure 28. North America Hemoperfusion Sales Value (2020-2031) & (US$ Million)
Figure 29. North America Hemoperfusion Sales Value by Country (%), 2024 VS 2031
Figure 30. Europe Hemoperfusion Sales Value, (2020-2031) & (US$ Million)
Figure 31. Europe Hemoperfusion Sales Value by Country (%), 2024 VS 2031
Figure 32. Asia Pacific Hemoperfusion Sales Value, (2020-2031) & (US$ Million)
Figure 33. Asia Pacific Hemoperfusion Sales Value by Region (%), 2024 VS 2031
Figure 34. South America Hemoperfusion Sales Value, (2020-2031) & (US$ Million)
Figure 35. South America Hemoperfusion Sales Value by Country (%), 2024 VS 2031
Figure 36. Middle East & Africa Hemoperfusion Sales Value, (2020-2031) & (US$ Million)
Figure 37. Middle East & Africa Hemoperfusion Sales Value by Country (%), 2024 VS 2031
Figure 38. Key Countries/Regions Hemoperfusion Sales Value (%), (2020-2031)
Figure 39. Key Countries/Regions Hemoperfusion Sales Volume (%), (2020-2031)
Figure 40. United States Hemoperfusion Sales Value, (2020-2031) & (US$ Million)
Figure 41. United States Hemoperfusion Sales Value by Type (%), 2024 VS 2031
Figure 42. United States Hemoperfusion Sales Value by Application (%), 2024 VS 2031
Figure 43. Europe Hemoperfusion Sales Value, (2020-2031) & (US$ Million)
Figure 44. Europe Hemoperfusion Sales Value by Type (%), 2024 VS 2031
Figure 45. Europe Hemoperfusion Sales Value by Application (%), 2024 VS 2031
Figure 46. China Hemoperfusion Sales Value, (2020-2031) & (US$ Million)
Figure 47. China Hemoperfusion Sales Value by Type (%), 2024 VS 2031
Figure 48. China Hemoperfusion Sales Value by Application (%), 2024 VS 2031
Figure 49. Japan Hemoperfusion Sales Value, (2020-2031) & (US$ Million)
Figure 50. Japan Hemoperfusion Sales Value by Type (%), 2024 VS 2031
Figure 51. Japan Hemoperfusion Sales Value by Application (%), 2024 VS 2031
Figure 52. South Korea Hemoperfusion Sales Value, (2020-2031) & (US$ Million)
Figure 53. South Korea Hemoperfusion Sales Value by Type (%), 2024 VS 2031
Figure 54. South Korea Hemoperfusion Sales Value by Application (%), 2024 VS 2031
Figure 55. Southeast Asia Hemoperfusion Sales Value, (2020-2031) & (US$ Million)
Figure 56. Southeast Asia Hemoperfusion Sales Value by Type (%), 2024 VS 2031
Figure 57. Southeast Asia Hemoperfusion Sales Value by Application (%), 2024 VS 2031
Figure 58. India Hemoperfusion Sales Value, (2020-2031) & (US$ Million)
Figure 59. India Hemoperfusion Sales Value by Type (%), 2024 VS 2031
Figure 60. India Hemoperfusion Sales Value by Application (%), 2024 VS 2031
Figure 61. Hemoperfusion Industrial Chain
Figure 62. Hemoperfusion Manufacturing Cost Structure
Figure 63. Channels of Distribution (Direct Sales, and Distribution)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed